InMode Ltd. Ordinary Shares (INMD) Stock: Buy, Sell, or Hold?

INMD - InMode Ltd. Ordinary Shares

Electromedical & Electrotherapeutic Apparatus
$14.05
-0.12 (-0.85%) ▼
5d: -0.99%
30d: -6.52%
90d: -5.07%
WAIT
LOW Confidence
Protect Your INMD Gains
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 18, 2026 at $14.35 · last confirmed Sep 28, 2026

Strength: 7.8/10

Get Alerted When INMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: INMD shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$16.59
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.30
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: INMD is currently trading at $14.05, which is considered oversold relative to its 30-day fair value range of $14.33 to $14.97. The stock's valuation (Forward PE: 10.2) is in line with its historical norms (9.5). At these levels, the market is pricing in 2.4% annual earnings growth.

Technical Outlook: Technically, INMD is in a uptrend. The price is currently testing key support at $13.97. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $16.17 (+15.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $14.33 - $14.97
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 84.2%

Protect Your Profits

Holding INMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (46/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($16.17)
  • BULLISH: Expecting earnings turnaround to 2.4% growth with None% revenue growth
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $14.33 - $14.97
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$0.49 (3.5%)

Support & Resistance Levels

Support Level $13.97
Resistance Level $14.62
Current Trend Uptrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.24
Wall Street Target $16.17 (+15.1%)
Earnings Growth (YoY) -31.0%
Profit Margin 20.7%
Valuation Premium vs History +2.4% premium
PE vs Historical 10.2 vs 9.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.4% (market-implied from PE analysis)
1-Year Target $14.39 (+2%)
2-Year Target $14.73 (+5%)
3-Year Target $15.09 (+7%)
3-Yr Target (if PE normalizes) (PE: 10→10) PE COMPRESSION $14.00 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.4, Growth: 5.9%) $33.21 (+136%)
Base: (SPY PE: 10.2, Growth: 5.9%) $16.67 (+19%)
Bear: (PE: 8.7, Growth: 5.9%) $14.17 (+1%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.71 | Current EPS (TTM): $1.21
Bull Case $17.67 (+26%)
Analyst growth 13.4%, PE expands to 12.9
Base Case $16.07 (+14%)
Market implied 13.4%, PE stable at 11.7
Bear Case $9.64 (-31%)
Severe decline -20.0%, PE contracts to 10.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 2:20 AM ET
Data refreshes hourly during market hours. Next update: 3:20 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INMD.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$61 62 BUY
SYK
Stryker Corporation
BUY
32 analysts
$369 64 BUY
MDT
Medtronic PLC
BUY
32 analysts
$105 52 HOLD
PODD
Insulet Corporation
STRONG BUY
24 analysts
$172 44 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$83 56 HOLD

Advanced INMD Option Strategies

Professional options setups generated by AI based on today's INMD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INMD

INMD Technical Chart INMD Price Prediction INMD Earnings Date INMD Investment Advisor INMD Fair Price Analyzer INMD Options Advisor INMD Options Chain INMD Options Analysis INMD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals